Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart.
Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart.
复制标题
DOI:
10.1161/circresaha.110.218487
复制
发表时间:
2010-08-06
影响因子:
20.1
通讯作者:
Leri A
中科院分区:
文献类型:
--
作者:
Urbanek K;Cabral-da-Silva MC;Ide-Iwata N;Maestroni S;Delucchi F;Zheng H;Ferreira-Martins J;Ogórek B;D'Amario D;Bauer M;Zerbini G;Rota M;Hosoda T;Liao R;Anversa P;Kajstura J;Leri A
Physiological hypertrophy in the developing heart has been considered the product of an increase in volume of preexisting fetal cardiomyocytes in the absence of myocyte formation. In this study, we tested whether the mouse heart possesses at birth a pool of cardiac stem cells (CSCs) which differentiate into myocytes contributing to the expansion of the parenchymal cell compartment postnatally. We have found that the newborn heart contains a population of c-kit-positive CSCs which are lineage negative, self-renewing and multipotent. CSCs express the Notch1 receptor and show the nuclear localization of its active fragment, N1ICD. In 60% of cases, N1ICD was coupled with the presence of Nkx2.5 indicating that the commitment of CSCs to the myocyte lineage is regulated by Notch1. Importantly, overexpression of N1ICD in neonatal CSCs expanded significantly the proportion of transit amplifying myocytes. To establish whether these in vitro findings had a functional counterpart in vivo, the Notch pathway was blocked in newborn mice by administration of a γ-secretase inhibitor. This intervention resulted in the development of a dilated myopathy and high mortality. Ventricular decompensation was characterized by a 62% reduction in amplifying myocytes which resulted in a 54% decrease in myocyte number. Following cessation of Notch blockade and recovery of myocyte regeneration, cardiac anatomy and function were largely restored. Notch1 signaling is a critical determinant of CSC growth and differentiation and when this cascade of events is altered cardiomyogenesis is impaired, physiological cardiac hypertrophy is prevented and a life threatening myopathy supervenes.